Methadone Matters
Informa Healthcare (Verlag)
978-1-84184-365-0 (ISBN)
- Titel ist leider vergriffen;
keine Neuauflage - Artikel merken
Methadone heals, but methadone kills. Methadone is a life-saving treatment, but methadone is also a life-threatening poison. The challenge is how to confer the benefit without incurring the harm. And that is what this book is all about. Methadone is by far the most widely prescribed drug in the treatment of heroin addiction, and yet, all too often, we are clumsy in our use of this powerful drug. So how much of the observed benefit is to do with methadone itself? Does dose matter? How important is the psychosocial component of care? How can problems of poor compliance be addressed? Is supervised consumption feasible, and, if so, is it justifiable and beneficial? And what is injectable methadone all about? When is it ever prescribed, and for whom, and how? And what about the dangers? Methadone itself can be the actual drug of overdose. How successful have efforts been made to re-structure methadone treatment to prevent overdose deaths? and how can the problems of diversion to the illicit market be kept to a minimum?
This multi-authored book, comprising chapters from the best of clinicians, researchers and policymakers, is the essential guide to increasing the relevance and effectiveness of methadone treatment. Like it or loathe it, Methadone Matters.
Dr Gillian Tober's research is in the process of treatment delivery, the effectiveness of addiction treatment and the nature and measurement of substance dependence. Her clinical work includes development of and supervision in the use of treatment manuals. Professor John Strang's involvement with the Department of Health has covered the period of the introduction of harm reduction initiatives, and also the preparation of the 'Orange Guidelines'; in both, a more competent use of methadone treatment is charted.
Section A: Introduction, background and scope
Section B: Aspects of clinical practice and variations
Section C: The special case of injectables
Section D: The risks
Section E: Service delivery
Section F: Special cases
Section G: Methadone studies
Section H: In conclusion
| Erscheint lt. Verlag | 3.4.2003 |
|---|---|
| Sprache | englisch |
| Maße | 156 x 235 mm |
| Gewicht | 662 g |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Suchtkrankheiten |
| Sozialwissenschaften ► Soziologie | |
| ISBN-10 | 1-84184-365-2 / 1841843652 |
| ISBN-13 | 978-1-84184-365-0 / 9781841843650 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
